Dr. David S. Ettinger, MD
- Medicare services, 2019
- 100
- Part D claims, 2018
- 20
- Publications
- 72
- Clinical trials
- 3
- Industry payments
- $68,034
- Practice address
- 600 N Wolfe St, Baltimore, MD 21287
- Practice phone
- Call (410) 583-2970
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Ettinger's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David S. Ettinger is a medical oncologist in Baltimore, Maryland
Dr. Ettinger practices in Baltimore, Maryland.
Dr. Ettinger's NPI, 1720016777, was assigned on June 29, 2006. Dr. Ettinger holds Maryland license D17207.
- NPI
- 1720016777NPI Registry (opens in a new tab)
- NPI enumeration date
- June 29, 2006
- NPI status
- Active
- Practice phone
- (410) 583-2970
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. David S. Ettinger's practice address is in Baltimore, Maryland
Dr. Ettinger's practice address in the NPI Registry is 600 N Wolfe St, Baltimore, MD 21287, in Baltimore City. The practice phone is (410) 583-2970.
- NPI Registry address600 N Wolfe St, Baltimore, MD 21287 · Baltimore CityPhone(410) 583-2970
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. David S. Ettinger's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ettinger practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Ettinger's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David S. Ettinger is one of 157 medical oncologists in Maryland
Medical oncology is Dr. Ettinger's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ettinger is licensed in Maryland.
Specialties and state licenses
- Medical oncology, MarylandPrimary
Medical oncologists near Dr. Ettinger
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David S. Ettinger billed Medicare for 100 services in 2019
CMS data shows 100 Medicare services from Dr. Ettinger across 2 procedure codes in 2019, all of them office visits. Medicare paid $10,293 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Ettinger's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Office and hospital visits
- 2018: 1262019: 10021%
- Other services
- 2018: 132019: 0100%
Dr. Ettinger compared with the Maryland median for medical oncologists, 2019
- Dr. Ettinger
- Maryland median
- Medicare services
- 100vs 42276% below
- Part D claims
- 20vs 11883% below
Medians across 124 medical oncologists in Maryland with Dmand AI profiles that report each measure.
Dr. Ettinger's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Ettinger?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ettinger and other medical oncologists in Maryland.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David S. Ettinger wrote 20 Medicare Part D claims in 2018
In 2018, Dr. Ettinger wrote 20 Medicare Part D claims. They cover 1 drug, with $209,154 in total drug cost. In 2017, CMS named 48 claims across 3 drugs.
Dr. Ettinger's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2017 to 2018
- 2017
- 2018
- Claims for drugs CMS names
- 2017: 482018: 2058%
Drugs named by CMS: 1 in 2018, 3 in 2017.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David S. Ettinger has 72 publications on record
Dmand AI links 72 papers to Dr. Ettinger, published from 2004 to 2023. 2019 was the busiest year, with 5. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Agents. Dr. Ettinger has published most often in J Natl Compr Canc Netw. Dr. Ettinger's most frequent co-authors are Patrick Forde, MD, Josephine Feliciano, MD and Christine Lee Hann, MD, PhD.
Dr. Ettinger's papers by year, 2014 to 2023
Topics Dr. Ettinger writes about most
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- ErbB Receptors
- Immunotherapy
- Receptor Protein-Tyrosine Kinases
- DNA Mutational Analysis
Dr. Ettinger's most frequent co-authors
- Patrick Forde, MD21 shared papers
- Josephine Feliciano, MD17 shared papers
- Christine Lee Hann, MD, PhD16 shared papers
Recent publications by Dr. Ettinger
See who Dr. Ettinger researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ettinger works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David S. Ettinger has worked on 3 clinical trials
Dmand AI links Dr. Ettinger to 3 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Carcinoma, Large Cell. Open Payments lists research payments to Dr. Ettinger that name 1 trial.
Conditions in Dr. Ettinger's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Carcinoma, Large Cell
- Neoplasms, Squamous Cell
Investigators on the most trials with Dr. Ettinger
Recent clinical trials with Dr. Ettinger
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC (opens in a new tab)
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David S. Ettinger received $68,034 in industry payments from 2016 to 2023
CMS Open Payments shows 90 general payments to Dr. Ettinger from 15 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $14,846. It also lists 1 research payment totaling $2,501 in 2020, naming 1 clinical trial.
General payments to Dr. Ettinger by program year, 2016 to 2023
General payments to Dr. Ettinger by kind, 2016 to 2023
- Consulting fees$49,68373%
- Travel and lodging$12,42418%
- Education speaker fees$3,2135%
- Food and beverage$2,6884%
- Education$270%
Companies that paid Dr. Ettinger the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. David S. Ettinger's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David S. Ettinger
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David S. Ettinger's NPI number?
Dr. David S. Ettinger's NPI number is 1720016777. It was assigned on June 29, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. David S. Ettinger?
Dr. David S. Ettinger is a medical oncologist in Baltimore, Maryland. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. David S. Ettinger practice?
Dr. Ettinger practices at 600 N Wolfe St, Baltimore, MD 21287.
What is Dr. David S. Ettinger's office phone number?
The practice phone on file for Dr. Ettinger is (410) 583-2970.
What is Dr. David S. Ettinger's medical license number?
Dr. Ettinger holds Maryland license D17207.
Does Dr. David S. Ettinger accept Medicare?
Yes. CMS data shows Dr. Ettinger billed Medicare for 100 services in 2019.
What services does Dr. David S. Ettinger bill to Medicare?
In 2019, Dr. Ettinger's most billed Medicare services were office visit, established patient (99215) and office visit, new patient (99205).
What drugs does Dr. David S. Ettinger prescribe most?
In 2018 Medicare Part D data, Dr. Ettinger's most prescribed drugs by claims were Xalkori.
Has Dr. David S. Ettinger received payments from drug or device companies?
CMS Open Payments shows $68,034 in general payments to Dr. Ettinger from 15 companies from 2016 to 2023. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. David S. Ettinger been practicing?
Dr. Ettinger's NPI was assigned in 2006.
Does Dr. David S. Ettinger do research?
Dmand AI links 72 publications to Dr. Ettinger, published from 2004 to 2023. Dr. Ettinger has worked on 3 clinical trials.
Who does Dr. David S. Ettinger publish with?
Dr. Ettinger's most frequent co-authors are Patrick Forde, MD (21 shared papers), Josephine Feliciano, MD (17 shared papers) and Christine Lee Hann, MD, PhD (16 shared papers).
Selling to medical oncology practices?
See medical oncologists in Maryland by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card